Literature DB >> 35873181

Concomitant acute limb ischemia and myocardial infarction: another challenge of COVID-19's hypercoagulability.

Ouissal Aissaoui1, Salem Husam1, Anass Mounir1, El Ghali Benouna2, Othmane Benmallem2, Chafik El Kettani1, Lahoucine Barrou1.   

Abstract

The COVID-19, actual pandemic due to SARS COV 2 is associated with numerous thromboembolic complications. Although venous thrombosis including pulmonary embolisms have been widely described, arterial localization seems rarely reported. Acute limb ischemia and myocardial infarction are two major consequences of arterial thrombosis and their concomitant occurrence among COVID-19 patients is extremely rare. It is an evident aspect of hypercoagulability and a real challenge to physicians. We herein describe the management of a 77 years old COVID-19 patient presenting an acute lower limb ischemia with concomitant myocardial infarction. He underwent coronary angiography with subsequent stent placement then was transferred to the operating room where a thrombectomy was performed. The outcome was poor as the cardiogenic shock persisted in addition to a reperfusion syndrome with multiorgan failure. AJCD
Copyright © 2022.

Entities:  

Keywords:  COVID-19; acute limb ischemia; acute myocardial infarction; hypercoagulability

Year:  2022        PMID: 35873181      PMCID: PMC9301031     

Source DB:  PubMed          Journal:  Am J Cardiovasc Dis        ISSN: 2160-200X


  7 in total

1.  Concomitant renal and splenic infarction as a complication of COVID-19: a case report and literature review.

Authors:  Maya Ramanathan; TeresaA Chueng; Edgar Fernandez; Jose Gonzales-Zamora
Journal:  Infez Med       Date:  2020-12-01

2.  Successful Simultaneous Revascularization for Acute Limb Ischemia and Concomitant Acute Myocardial Infarction.

Authors:  Keisuke Miyake; Shinsuke Kikuchi; Yuya Kitani; Atsuhiro Koya; Toshiharu Takeuchi; Naoyuki Hasebe; Yoshiki Sawa; Nobuyoshi Azuma
Journal:  Ann Vasc Dis       Date:  2018-09-25

Review 3.  The Role of Anticoagulation in COVID-19-Induced Hypercoagulability.

Authors:  Juan Simon Rico-Mesa; Daniel Rosas; Ashkan Ahmadian-Tehrani; Averi White; Allen S Anderson; Robert Chilton
Journal:  Curr Cardiol Rep       Date:  2020-06-17       Impact factor: 2.931

4.  A case report of multisite arterial thrombosis in a patient with coronavirus disease 2019 (COVID-19).

Authors:  Marco Angelillis; Marco De Carlo; Andrea Christou; Michele Marconi; Davide M Mocellin; Paolo Caravelli; Raffaele De Caterina; Anna S Petronio
Journal:  Eur Heart J Case Rep       Date:  2020-12-21

Review 5.  COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.

Authors:  Wolfgang Miesbach; Michael Makris
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

6.  Acute Splenic Artery Thrombosis and Infarction Associated with COVID-19 Disease.

Authors:  Osama Qasim Agha; Ryan Berryman
Journal:  Case Rep Crit Care       Date:  2020-09-04

7.  Acute limb ischemia with concomitant splenic and renal infarcts: Thromboembolic events revealing COVID-19.

Authors:  Samia Berrichi; Zakaria Bouayed; Sara Berrajaa; Sanae El Mezzeoui; Amal Moujahid; Siham Nasri; Houssam Bkiyar; Imane Skiker; Brahim Housni
Journal:  Ann Med Surg (Lond)       Date:  2021-07-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.